hli logo
Normal view MARC view
  • Treatment advances in Hodgkin's disease have resulted in many patients achieving long-term survival, and the late complication of second malignancies is being increasingly recognized. The occurrence of Burkitt's lymphoma following chemotherapy or combined-modality treatment for Hodgkin's disease has previously been documented. Its development has not, to the best of our knowledge, been described following irradiation alone. We report a male patient with Hodgkin's disease treated by mantle irradiation who subsequently died from Burkitt's lymphoma. Theories of pathogenesis are presented.

Treatment advances in Hodgkin's disease have resulted in many patients achieving long-term survival, and the late complication of second malignancies is being increasingly recognized. The occurrence of Burkitt's lymphoma following chemotherapy or combined-modality treatment for Hodgkin's disease has previously been documented. Its development has not, to the best of our knowledge, been described following irradiation alone. We report a male patient with Hodgkin's disease treated by mantle irradiation who subsequently died from Burkitt's lymphoma. Theories of pathogenesis are presented. (Topical Term)

Preferred form: Treatment advances in Hodgkin's disease have resulted in many patients achieving long-term survival, and the late complication of second malignancies is being increasingly recognized. The occurrence of Burkitt's lymphoma following chemotherapy or combined-modality treatment for Hodgkin's disease has previously been documented. Its development has not, to the best of our knowledge, been described following irradiation alone. We report a male patient with Hodgkin's disease treated by mantle irradiation who subsequently died from Burkitt's lymphoma. Theories of pathogenesis are presented.

Machine generated authority record.

Work cat.: (OSt)7440: Carney, Desmond. 32888, Burkitt's lymphoma in a patient previously treated for Hodgkin's disease. , 1989.